Publication: Intranasal inhalation of beclomethasone dipropionate in the treatment of perennial rhinitis in adults
| dc.contributor.author | C. Bunnag | en_US |
| dc.contributor.author | P. Vipulakom | en_US |
| dc.contributor.author | P. Pacharee | en_US |
| dc.contributor.author | C. Siriyananda | en_US |
| dc.contributor.other | Mahidol University | en_US |
| dc.date.accessioned | 2018-04-30T08:37:26Z | |
| dc.date.available | 2018-04-30T08:37:26Z | |
| dc.date.issued | 1980-01-01 | en_US |
| dc.description.abstract | Forty-eight perennial rhinitis patients completed a six weeks' open trial of intranasal beclomethasone dipropionate aerosol. Each received a daily dose of 400 micrograms. Thirty-five responded excellently, seven reported satisfactory improvement and six failed. This study indicated that patients with a demonstrable allergic component responded favorably. However, due to the wide margin of safety the authors suggest that it be tried in non-infective perennial rhinitis with no demonstrable allergic component as well. | en_US |
| dc.identifier.citation | Annals of Allergy. Vol.44, No.2 (1980), 100-105 | en_US |
| dc.identifier.issn | 00034738 | en_US |
| dc.identifier.other | 2-s2.0-0018844326 | en_US |
| dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/11159 | |
| dc.rights | Mahidol University | en_US |
| dc.rights.holder | SCOPUS | en_US |
| dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0018844326&origin=inward | en_US |
| dc.subject | Medicine | en_US |
| dc.title | Intranasal inhalation of beclomethasone dipropionate in the treatment of perennial rhinitis in adults | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0018844326&origin=inward | en_US |